C H Ramírez-Ronda

1.2k total citations
40 papers, 904 citations indexed

About

C H Ramírez-Ronda is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, C H Ramírez-Ronda has authored 40 papers receiving a total of 904 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 15 papers in Epidemiology and 14 papers in Pharmacology. Recurrent topics in C H Ramírez-Ronda's work include Antibiotics Pharmacokinetics and Efficacy (12 papers), Antibiotic Resistance in Bacteria (11 papers) and Pneumonia and Respiratory Infections (8 papers). C H Ramírez-Ronda is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (12 papers), Antibiotic Resistance in Bacteria (11 papers) and Pneumonia and Respiratory Infections (8 papers). C H Ramírez-Ronda collaborates with scholars based in Puerto Rico, United States and Australia. C H Ramírez-Ronda's co-authors include Jay P. Sanford, Randall K. Holmes, Katherine A. Gould, María E. Álvarez, Sonia Saavedra, Carlos D. García, Robert A. Schwartz, Elliot Frank, Robert S. Schwartz and Gladys E. Sather and has published in prestigious journals such as Journal of Clinical Investigation, Annals of Internal Medicine and Clinical Infectious Diseases.

In The Last Decade

C H Ramírez-Ronda

40 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C H Ramírez-Ronda Puerto Rico 16 415 348 260 146 114 40 904
J. L. Vildé France 17 420 1.0× 583 1.7× 158 0.6× 110 0.8× 64 0.6× 50 1.1k
Claudine E. Fasching United States 18 181 0.4× 429 1.2× 171 0.7× 141 1.0× 41 0.4× 30 1.1k
Sayomporn Sirinavin Thailand 19 463 1.1× 243 0.7× 285 1.1× 46 0.3× 44 0.4× 48 1.0k
Jennifer S. Daly United States 16 639 1.5× 430 1.2× 187 0.7× 68 0.5× 140 1.2× 36 1.2k
J Modaï France 20 622 1.5× 620 1.8× 100 0.4× 211 1.4× 232 2.0× 87 1.3k
Emanuel Wolinsky United States 17 445 1.1× 592 1.7× 444 1.7× 76 0.5× 33 0.3× 34 1.3k
Antonia Kolokathis United States 12 363 0.9× 442 1.3× 59 0.2× 75 0.5× 59 0.5× 15 788
Marvin J. Tenenbaum United States 14 388 0.9× 305 0.9× 210 0.8× 61 0.4× 24 0.2× 22 757
Anand P. Panwalker United States 13 189 0.5× 257 0.7× 63 0.2× 168 1.2× 39 0.3× 27 651
Josephine M. Ehret United States 18 191 0.5× 372 1.1× 122 0.5× 118 0.8× 24 0.2× 32 906

Countries citing papers authored by C H Ramírez-Ronda

Since Specialization
Citations

This map shows the geographic impact of C H Ramírez-Ronda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C H Ramírez-Ronda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C H Ramírez-Ronda more than expected).

Fields of papers citing papers by C H Ramírez-Ronda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C H Ramírez-Ronda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C H Ramírez-Ronda. The network helps show where C H Ramírez-Ronda may publish in the future.

Co-authorship network of co-authors of C H Ramírez-Ronda

This figure shows the co-authorship network connecting the top 25 collaborators of C H Ramírez-Ronda. A scholar is included among the top collaborators of C H Ramírez-Ronda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C H Ramírez-Ronda. C H Ramírez-Ronda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramírez-Ronda, C H, et al.. (2005). Prosthetic valve endocarditis.. PubMed. 97(3 Pt 2). 168–77. 1 indexed citations
2.
Hawkins, David, Nathan Clumeck, David A. Cooper, et al.. (2000). Randomised, Multicentre Phase III Study of Saquinavir plus Zidovudine plus Zalcitabine in Previously Untreated or Minimally Pretreated HIV-Infected Patients. Clinical Drug Investigation. 20(5). 295–307. 13 indexed citations
3.
Shepp, David H., C H Ramírez-Ronda, Lawrence Dall, et al.. (1997). A Comparative Trial of Zidovudine Administered Every Four Versus Every Twelve Hours for the Treatment of Advanced HIV Disease. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 15(4). 283–288. 6 indexed citations
4.
Schooley, Robert T., C H Ramírez-Ronda, Joep M. A. Lange, et al.. (1996). Virologic and Immunologic Benefits of Initial Combination Therapy with Zidovudine and Zalcitabine or Didanosine Compared with Zidovudine Monotherapy. The Journal of Infectious Diseases. 173(6). 1354–1366. 68 indexed citations
5.
Schwartz, Robert A., et al.. (1996). Current and future management of serious skin and skin-structure infections. The American Journal of Medicine. 100(6). 90S–95S. 29 indexed citations
6.
Petersen, E. A., C H Ramírez-Ronda, William D. Hardy, et al.. (1995). Dose-Related Activity Of Stavudine In Patients Infected With Human Immunodeficiency Virus. The Journal of Infectious Diseases. 171(Supplement 2). S131–S139. 48 indexed citations
7.
Ramírez-Ronda, C H, et al.. (1989). Brief report: Comparative, double-blind study of intravenous ciprofloxacin and intravenous ceftazidime in serious infection. The American Journal of Medicine. 87(5). S195–S197. 4 indexed citations
9.
Ramírez-Ronda, C H. (1987). Quinolones in the treatment of gastrointestinal infections.. PubMed. 6(2 Suppl). 488–9. 1 indexed citations
10.
Ramírez-Ronda, C H, et al.. (1987). Treatment of urinary tract infection with norfloxacin. The American Journal of Medicine. 82(6). 75–78. 9 indexed citations
11.
Ramírez-Ronda, C H, et al.. (1986). Ciprofloxacin in the treatment of urinary tract infections caused byPseudomonas aeruginosa and multiresistant bacteria. European Journal of Clinical Microbiology & Infectious Diseases. 5(2). 255–257. 11 indexed citations
12.
Saavedra, Sonia, et al.. (1986). Susceptibility of aerobic gram-negative bacilli to aminoglycosides: Effects of 45 months of amikacin as first-line aminoglycoside therapy. The American Journal of Medicine. 80(6). 65–70. 28 indexed citations
13.
Ramírez-Ronda, C H, et al.. (1985). Efficacy and safety of aztreonam versus tobramycin for aerobic gram-negative bacilli lower respiratory tract infections. The American Journal of Medicine. 78(2). 42–43. 11 indexed citations
14.
Ramírez-Ronda, C H, et al.. (1983). In Vitro Susceptibility of 50 Non-β-Lactamase-Producing Neisseria gonorrhoeae Strains to 12 Antimicrobial Agents. Antimicrobial Agents and Chemotherapy. 23(2). 242–244. 14 indexed citations
15.
Ramírez-Ronda, C H, et al.. (1982). Granulomatous Hepatitis. Clinical Infectious Diseases. 4(3). 638–655. 45 indexed citations
16.
Ramírez-Ronda, C H, et al.. (1982). Activity of N-formimidoyl thienamycin and cephalosporins against isolates from nosocomially acquired bacteremia. Antimicrobial Agents and Chemotherapy. 21(3). 509–512. 8 indexed citations
17.
Ramírez-Ronda, C H, et al.. (1982). Comparative effectiveness, safety and tolerance of mezlocillin and ticarcillin: A prospective randomized trial. Journal of Antimicrobial Chemotherapy. 9(suppl A). 125–129. 8 indexed citations
18.
Ramírez-Ronda, C H. (1981). Increased Pharyngeal Bacterial Colonization During Viral Illness. Archives of Internal Medicine. 141(12). 1599–1599. 36 indexed citations
19.
Ramírez-Ronda, C H, Randall K. Holmes, & Jay P. Sanford. (1975). Effects of Divalent Cations on Binding of Aminoglycoside Antibiotics to Human Serum Proteins and to Bacteria. Antimicrobial Agents and Chemotherapy. 7(3). 239–245. 45 indexed citations
20.
Ramírez-Ronda, C H & Jay P. Sanford. (1975). Clindamycin: A Trojan Horse?. Archives of Otolaryngology - Head and Neck Surgery. 101(4). 235–237. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026